GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (SZSE:002399) » Definitions » Days Inventory

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Days Inventory : 611.03 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Shenzhen Hepalink Pharmaceutical Group Co's Average Total Inventories for the three months ended in Sep. 2024 was ¥5,818 Mil. Shenzhen Hepalink Pharmaceutical Group Co's Cost of Goods Sold for the three months ended in Sep. 2024 was ¥869 Mil. Hence, Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory for the three months ended in Sep. 2024 was 611.03.

The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory or its related term are showing as below:

SZSE:002399' s Days Inventory Range Over the Past 10 Years
Min: 137.09   Med: 228.82   Max: 675.78
Current: 650.05

During the past 13 years, Shenzhen Hepalink Pharmaceutical Group Co's highest Days Inventory was 675.78. The lowest was 137.09. And the median was 228.82.

SZSE:002399's Days Inventory is ranked worse than
97.46% of 944 companies
in the Drug Manufacturers industry
Industry Median: 156.935 vs SZSE:002399: 650.05

Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory declined from Sep. 2023 (756.10) to Sep. 2024 (611.03).

Inventory Turnover measures how fast the company turns over its inventory within a year. Shenzhen Hepalink Pharmaceutical Group Co's Inventory Turnover for the three months ended in Sep. 2024 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shenzhen Hepalink Pharmaceutical Group Co's Inventory-to-Revenue for the three months ended in Sep. 2024 was 4.72.


Shenzhen Hepalink Pharmaceutical Group Co Days Inventory Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Days Inventory Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 253.19 311.16 331.78 436.92 675.78

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 756.10 713.52 659.14 594.04 611.03

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory falls into.



Shenzhen Hepalink Pharmaceutical Group Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (6843.906 + 6654.111) / 2 ) / 3645.269*365
=6749.0085 / 3645.269*365
=675.78

Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:

Days Inventory (Q: Sep. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Sep. 2024 )) / count ) / Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=( (6022.241 + 5612.822) / 2 ) / 868.78*365 / 4
=5817.5315 / 868.78*365 / 4
=611.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Hepalink Pharmaceutical Group Co  (SZSE:002399) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shenzhen Hepalink Pharmaceutical Group Co's Inventory Turnover for the three months ended in Sep. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shenzhen Hepalink Pharmaceutical Group Co's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Shenzhen Hepalink Pharmaceutical Group Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.
Executives
Zhang Ping Director
Li Li Director
Kong Yun Executives
Li Tan Directors, executives

Shenzhen Hepalink Pharmaceutical Group Co Headlines

No Headlines